Valuation: Ambu

Market Cap 18.27B 2.79B 2.44B 2.26B 2.08B 3.94B 267B 4.02B 26.98B 10.58B 131B 10.46B 10.23B 452B P/E 2026 *
30.1x
P/E 2027 * 22.4x
Enterprise Value 17.8B 2.71B 2.38B 2.2B 2.03B 3.84B 260B 3.91B 26.28B 10.31B 128B 10.19B 9.97B 441B EV / Sales 2026 *
2.75x
EV / Sales 2027 * 2.44x
Free-Float
86.18%
Yield 2026 *
0.65%
Yield 2027 * 0.84%
Manager TitleAgeSince
Chief Executive Officer 53 2022-05-19
Director of Finance/CFO 42 2023-12-31
Chief Operating Officer 53 2024-06-09
Director TitleAgeSince
Chairman 58 2020-12-08
Director/Board Member 58 2021-12-13
Director/Board Member 63 2021-12-13
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 2.77B
-1.94%-3.68%-30.23%-14.51% 164B
-0.36%+0.61%-7.06%-5.09% 107B
+0.89%+2.54%+3.70%+60.04% 59.04B
+0.10%-0.41%+40.56%+55.35% 51.72B
+1.24%-1.10%-12.58%-40.82% 41.87B
-1.12%-5.08% - - 34.7B
+1.85%+5.48%-8.42%-43.01% 28.93B
+1.69%+0.58%+58.33%-6.25% 24.99B
+0.49%+1.77%-4.82%-5.11% 21.05B
Average +0.30%-0.35%+4.94%+0.08% 59.25B
Weighted average by Cap. -0.32%-0.96%-5.62%+0.54%

Financials

2026 *2027 *
Net sales 6.46B 985M 864M 800M 736M 1.39B 94.3B 1.42B 9.54B 3.74B 46.31B 3.7B 3.62B 160B 7.18B 1.1B 961M 890M 819M 1.55B 105B 1.58B 10.61B 4.16B 51.5B 4.11B 4.02B 178B
Net income 609M 92.9M 81.48M 75.47M 69.44M 131M 8.89B 134M 899M 353M 4.37B 349M 341M 15.08B 810M 124M 108M 100M 92.33M 175M 11.82B 178M 1.2B 469M 5.81B 464M 454M 20.05B
Net Debt -474M -72.35M -63.46M -58.78M -54.08M -102M -6.93B -104M -701M -275M -3.4B -272M -266M -11.74B -761M -116M -102M -94.31M -86.77M -164M -11.11B -167M -1.12B -441M -5.46B -436M -426M -18.84B
Logo Ambu
Ambu A/S is specialized in the design, production and marketing of medical supplies. Net sales break down by family of products as follows: - emergency care and resuscitation devices (50.8%): mechanical ventilation devices (insufflators, laryngeal masks, facial masks and respiratory bags), secretion aspirators, immobilization devices, etc. In addition, the group sells dummies for first aid training centers; - single-use endoscopes (30.2%); - monitoring and diagnostic devices (19%): including electrodes used in the fields of cardiology, neurophysiology and first aid. At the end of September 2025, Ambu A/S had four production sites located in China, Malaysia, the United States and Mexico. Net sales are distributed geographically as follows: Denmark (1%), Europe (38.9%), the United States (49.3%), North America (1.2%) and other (9.6%).
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
BBB